1. A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease. Issue 6 (8th March 2021) Authors: Åberg, Fredrik; Danford, Christopher J.; Thiele, Maja; Talbäck, Mats; Rasmussen, Ditlev Nytoft; Jiang, Z. Gordon; Hammar, Niklas; Nasr, Patrik; Ekstedt, Mattias; But, Anna; Puukka, Pauli; Krag, Aleksander; Sundvall, Jouko; Erlund, Iris; Salomaa, Veikko; Stål, Per; Kechagias, Stergios; Hultcrantz,... Journal: Hepatology communications Issue: Volume 5:Issue 6(2021) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis. Issue 11 (November 2021) Authors: Björkström, Karl; Stål, Per; Holmer, Magnus; Bengtsson, Bonnie; Staaf, Annika; Hoffstedt, Johan; Hagström, Hannes Journal: European journal of gastroenterology & hepatology Issue: Volume 33:Issue 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alcohol and drug use prior to liver transplantation: more common than expected in patients with non-alcoholic liver disease. (2nd September 2019) Authors: Schult, Andreas; Stokkeland, Knut; Ericzon, Bo-Göran; Hultcrantz, Rolf; Franck, Johan; Stål, Per; Castedal, Maria Journal: Scandinavian journal of gastroenterology Issue: Volume 54:Number 9(2019) Page Start: 1146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alcohol as a risk factor for mortality in liver transplant patients in Sweden. (4th March 2023) Authors: Castedal, Maria; Schult, Andreas; Kotopouli, Maria Ioanna; Bottai, Matteo; Franck, Johan; Ericzon, Bo-Göran; Stål, Per; Stokkeland, Knut Journal: Scandinavian journal of gastroenterology Issue: Volume 58:Number 3(2023) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?. (20th January 2015) Authors: Edenvik, Pia; Davidsdottir, Loa; Oksanen, Antti; Isaksson, Bengt; Hultcrantz, Rolf; Stål, Per Journal: Liver international Issue: Volume 35:Number 7(2015:Jul.) Page Start: 1862 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cardiovascular risk factors in non‐alcoholic fatty liver disease. (17th October 2018) Authors: Hagström, Hannes; Nasr, Patrik; Ekstedt, Mattias; Hammar, Ulf; Stål, Per; Askling, Johan; Hultcrantz, Rolf; Kechagias, Stergios Journal: Liver international Issue: Volume 39:Number 1(2019) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis. (29th March 2019) Authors: Bengtsson, Bonnie; Stål, Per; Wahlin, Staffan; Björkström, Niklas K.; Hagström, Hannes Journal: Liver international Issue: Volume 39:Number 6(2019) Page Start: 1098 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting. (3rd July 2019) Authors: Karalli, Amar; Teiler, Johan; Haji, Mojgan; Seth, Elin; Brismar, Torkel B.; Wahlin, Staffan; Axelsson, Rimma; Stål, Per Journal: Scandinavian journal of gastroenterology Issue: Volume 54:Number 7(2019) Page Start: 905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up. (11th October 2022) Authors: Holmer, Magnus; Ekstedt, Mattias; Nasr, Patrik; Zenlander, Robin; Wester, Axel; Tavaglione, Federica; Romeo, Stefano; Kechagias, Stergios; Stål, Per; Hagström, Hannes Journal: Liver international Issue: Volume 42:Number 12(2022) Page Start: 2769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Elevated serum ferritin is associated with increased mortality in non‐alcoholic fatty liver disease after 16 years of follow‐up. (28th April 2016) Authors: Hagström, Hannes; Nasr, Patrik; Bottai, Matteo; Ekstedt, Mattias; Kechagias, Stergios; Hultcrantz, Rolf; Stål, Per Journal: Liver international Issue: Volume 36:Number 11(2016) Page Start: 1688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗